{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:16:38Z","timestamp":1791656198688,"version":"4.3.4"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100019345","name":"King Salman Center for Disability Research","doi-asserted-by":"publisher","award":["KSRG-2024-307"],"award-info":[{"award-number":["KSRG-2024-307"]}],"id":[{"id":"10.13039\/501100019345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"DOI":"10.1007\/s12031-025-02337-4","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T06:00:22Z","timestamp":1745560822000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Unraveling the Complexity of Alzheimer\u2019s Disease: Insights into Etiology and Advancements in Treatment Strategies"],"prefix":"10.1007","volume":"75","author":[{"given":"Bakhtawar","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Khalid","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ajmal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubin Mustafa","family":"Kiyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"2337_CR1","doi-asserted-by":"crossref","unstructured":"Aderinto N, Olatunji G, Abdulbasit M, Olajide TN, Kokori E (2023) Examining the efficacy of the Mediterranean-DASH diet intervention for neurodegenerative delay in mitigating cognitive decline. Egypt J Neurol Psychiatry Neurosurg 59(1):145","DOI":"10.1186\/s41983-023-00752-1"},{"issue":"2","key":"2337_CR2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1080\/13561820.2022.2060194","volume":"37","author":"A Aguirre","year":"2023","unstructured":"Aguirre A et al (2023) Designing an interprofessional dementia specialty clinic: conceptualization and evaluation of a patient-centered model. J Interprof Care 37(2):254\u2013261","journal-title":"J Interprof Care"},{"key":"2337_CR3","unstructured":"Akyuz, E., et al., (2024)\u00a0An expanded narrative review of neurotransmitters on Alzheimer\u2019s disease: the role of therapeutic interventions on neurotransmission. Mol Neurobiol p. 1\u201344"},{"key":"2337_CR4","first-page":"1097","volume":"10","author":"A Albini","year":"2024","unstructured":"Albini A, La Vecchia C, Magnoni F, Garrone O, Morelli D, Janssens JP, Corso G (2024) Physical activity and exercise health benefits: cancer prevention, interception, and survival. Eur J Cancer Prev 10:1097","journal-title":"Eur J Cancer Prev"},{"key":"2337_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.mito.2023.05.007","volume":"71","author":"T Alqahtani","year":"2023","unstructured":"Alqahtani T et al (2023) Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease, and Parkinson\u2019s disease, Huntington\u2019s disease and amyotrophic lateral sclerosis-an updated review. Mitochondrion 71:83\u201392","journal-title":"Mitochondrion"},{"issue":"4","key":"2337_CR6","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/alz.12638","volume":"18","author":"Alzheimer\u2019s disease facts and figures","year":"2022","unstructured":"Alzheimer\u2019s disease facts and figures (2022) Alzheimers Dement 18(4):700\u2013789","journal-title":"Alzheimers Dement"},{"issue":"5","key":"2337_CR7","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1002\/alz.13809","volume":"20","author":"Alzheimer\u2019s disease facts and figures","year":"2024","unstructured":"Alzheimer\u2019s disease facts and figures (2024) Alzheimers Dement 20(5):3708\u20133821","journal-title":"Alzheimers Dement"},{"key":"2337_CR8","doi-asserted-by":"crossref","unstructured":"Anderson ND, Murphy KJ, Troyer AK (2024) Living with mild cognitive impairment: a guide to maximizing brain health and reducing the risk of dementia: Oxford University Press","DOI":"10.1093\/oso\/9780197749340.001.0001"},{"key":"2337_CR9","doi-asserted-by":"crossref","unstructured":"Arafah, A., et al., (2023)\u00a0The future of precision medicine in the cure of Alzheimer\u2019s disease. Biomed 11(2)","DOI":"10.3390\/biomedicines11020335"},{"key":"2337_CR10","doi-asserted-by":"crossref","unstructured":"Ardura-Fabregat A, Boddeke E, Boza-Serrano A, Brioschi S, Castro-Gomez S, Ceyz\u00e9riat K, Heneka MT (2017) Targeting neuroinflammation to treat Alzheimer\u2019s disease. CNS drugs 31:1057\u20131082","DOI":"10.1007\/s40263-017-0483-3"},{"key":"2337_CR11","doi-asserted-by":"publisher","first-page":"1213223","DOI":"10.3389\/fnut.2023.1213223","volume":"10","author":"S Arora","year":"2023","unstructured":"Arora S et al (2023) Diet and lifestyle impact the development and progression of Alzheimer\u2019s dementia. Front Nutr 10:1213223","journal-title":"Front Nutr"},{"key":"2337_CR12","doi-asserted-by":"crossref","unstructured":"Balsamo S, Willardson JM, Frederico SD, Prestes J, Balsamo DC, Dahan DC, dos Santos-Neto L, Nobrega OT (2013) Effectiveness of exercise on cognitive impairment and Alzheimer\u2019s disease. Int J Gen Med 387\u201339","DOI":"10.2147\/IJGM.S35315"},{"key":"2337_CR13","doi-asserted-by":"crossref","unstructured":"Bansal A, Salaria M, Singh TR (2019) Tau pathology: a step towards understanding neurodegenerative disorders network complexity. In Handbook of Research on Critical Examinations of Neurodegenerative Disorders (pp 217\u2013234): IGI Global","DOI":"10.4018\/978-1-5225-5282-6.ch010"},{"key":"2337_CR14","doi-asserted-by":"crossref","unstructured":"Barnes LL, Dhana K, Liu X, Carey VJ, Ventrelle J, Johnson K, Stubbs BJ (2023) Trial of the MIND diet for prevention of cognitive decline in older persons. New England J Medicine 389(7):602\u2013611","DOI":"10.1056\/NEJMoa2302368"},{"key":"2337_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1471-2377-14-101","volume":"14","author":"JH Barnett","year":"2014","unstructured":"Barnett JH et al (2014) Early intervention in Alzheimer\u2019s disease: a health economic study of the effects of diagnostic timing. BMC Neurol 14:101","journal-title":"BMC Neurol"},{"issue":"4","key":"2337_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/0891988710383571","volume":"23","author":"LM Bekris","year":"2010","unstructured":"Bekris LM et al (2010) Genetics of Alzheimer disease. J Geriatr Psychiatry Neurol 23(4):213\u2013227","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"2337_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.conb.2019.11.024","volume":"61","author":"C Bellenguez","year":"2020","unstructured":"Bellenguez C, Grenier-Boley B, Lambert J-C (2020) Genetics of Alzheimer\u2019s disease: where we are, and where we are going. Curr Opin Neurobiol 61:40\u201348","journal-title":"Curr Opin Neurobiol"},{"key":"2337_CR18","unstructured":"Berestetska, V., (2023)Environmental factors in the development of Alzheimer\u2019s disease. Ann Innov Med 1(2)"},{"issue":"4","key":"2337_CR19","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.3233\/JAD-180983","volume":"68","author":"CM Black","year":"2019","unstructured":"Black CM et al (2019) Relationship between treatment initiation and healthcare costs in Alzheimer\u2019s disease. J Alzheimers Dis 68(4):1575\u20131585","journal-title":"J Alzheimers Dis"},{"key":"2337_CR20","doi-asserted-by":"crossref","unstructured":"Breijyeh, Z. and R. Karaman, (2020)\u00a0Comprehensive review on Alzheimer\u2019s disease: causes and treatment. Mol 25(24).","DOI":"10.3390\/molecules25245789"},{"key":"2337_CR21","doi-asserted-by":"publisher","unstructured":"Buckley MT, Sun ED, George BM, Liu L, Schaum N, Xu L, Brunet A (2023) Cell-type-specific aging clocks to quantify aging and rejuvenation in neurogenic regions of the brain. Nat Aging 3(1):121\u2013137. https:\/\/doi.org\/10.1038\/s43587-022-00335-4","DOI":"10.1038\/s43587-022-00335-4"},{"issue":"1","key":"2337_CR22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13195-024-01534-4","volume":"16","author":"JH Byeon","year":"2024","unstructured":"Byeon JH et al (2024) Moderation of thyroid hormones for the relationship between amyloid and tau pathology. Alzheimers Res Ther 16(1):164","journal-title":"Alzheimers Res Ther"},{"key":"2337_CR23","doi-asserted-by":"publisher","first-page":"856376","DOI":"10.3389\/fimmu.2022.856376","volume":"13","author":"Y Cai","year":"2022","unstructured":"Cai Y et al (2022) Microglia in the neuroinflammatory pathogenesis of Alzheimer\u2019s disease and related therapeutic targets. Front Immunol 13:856376","journal-title":"Front Immunol"},{"issue":"5","key":"2337_CR24","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/jgs.14808","volume":"65","author":"CM Callahan","year":"2017","unstructured":"Callahan CM (2017) Alzheimer\u2019s disease: individuals, dyads, communities, and costs. J Am Geriatr Soc 65(5):892\u2013895","journal-title":"J Am Geriatr Soc"},{"key":"2337_CR25","doi-asserted-by":"publisher","unstructured":"Carrera I, Etcheverr\u00eda I, Fern\u00e1ndez-Novoa L, Lombardi V, Cacabelos R, Vigo C (2012) Vaccine development to treat Alzheimer\u2019s Disease Neuropathology in APP\/PS1 Transgenic Mice. Int J Alzheimers Dis 2012:376138. https:\/\/doi.org\/10.1155\/2012\/376138","DOI":"10.1155\/2012\/376138"},{"key":"2337_CR26","doi-asserted-by":"crossref","unstructured":"Castello, M.A. and S. Soriano, (2014)\u00a0On the origin of Alzheimer\u2019s disease. Trials and tribulations of the amyloid hypothesis. Age res rev 13: p. 10\u201312.","DOI":"10.1016\/j.arr.2013.10.001"},{"issue":"11","key":"2337_CR27","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.3390\/antiox12112011","volume":"12","author":"E Catalani","year":"2023","unstructured":"Catalani E et al (2023) Targeting mitochondrial dysfunction and oxidative stress to prevent the neurodegeneration of retinal ganglion cells. Antioxidants 12(11):2011","journal-title":"Antioxidants"},{"key":"2337_CR28","doi-asserted-by":"publisher","first-page":"104223","DOI":"10.1016\/j.bspc.2022.104223","volume":"80","author":"J Chaki","year":"2023","unstructured":"Chaki J, Wo\u017aniak M (2023) Deep learning for neurodegenerative disorder (2016 to 2022): a systematic review. Biomed Signal Process Control 80:104223","journal-title":"Biomed Signal Process Control"},{"key":"2337_CR29","doi-asserted-by":"crossref","unstructured":"Chen, Z.R., et al., (2022)\u00a0Role of cholinergic signaling in Alzheimer\u2019s disease. Mol 27(6).","DOI":"10.3390\/molecules27061816"},{"issue":"1","key":"2337_CR30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","volume":"20","author":"Y Chen","year":"2023","unstructured":"Chen Y, Yu Y (2023) Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation. J Neuroinflammation 20(1):165","journal-title":"J Neuroinflammation"},{"issue":"3","key":"2337_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/brain.2011.0025","volume":"1","author":"G Chen","year":"2011","unstructured":"Chen G et al (2011) Negative functional connectivity and its dependence on the shortest path length of positive network in the resting-state human brain. Brain Connect 1(3):195\u2013206","journal-title":"Brain Connect"},{"issue":"7","key":"2337_CR32","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.3390\/molecules29071478","volume":"29","author":"H Chen","year":"2024","unstructured":"Chen H et al (2024) Neuroinflammation of microglial regulation in Alzheimer\u2019s disease: therapeutic approaches. Molecules 29(7):1478","journal-title":"Molecules"},{"issue":"10","key":"2337_CR33","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.3390\/ijms19103082","volume":"19","author":"H Chi","year":"2018","unstructured":"Chi H, Chang H-Y, Sang T-K (2018) Neuronal cell death mechanisms in major neurodegenerative diseases. Int J Mol Sci 19(10):3082","journal-title":"Int J Mol Sci"},{"issue":"23","key":"2337_CR34","doi-asserted-by":"publisher","first-page":"9036","DOI":"10.3390\/ijms21239036","volume":"21","author":"A Chiarini","year":"2020","unstructured":"Chiarini A et al (2020) Danger-sensing\/patten recognition receptors and neuroinflammation in Alzheimer\u2019s disease. Int J Mol Sci 21(23):9036","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2337_CR35","first-page":"e31065","volume":"14","author":"E Chin","year":"2022","unstructured":"Chin E et al (2022) Conventional versus new treatment: comparing the effects of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptor antagonist with aducanumab. Cureus 14(11):e31065","journal-title":"Cureus"},{"key":"2337_CR36","doi-asserted-by":"publisher","unstructured":"Cisse M, Braun U, Leitges M, Fisher A, Pages G, Checler F, Vincent B (2011) ERK1-independent \u03b1-secretase cut of \u03b2-amyloid precursor protein via M1 muscarinic receptors and PKC\u03b1\/\u03b5. Mol Cell Neurosci 47(3):223\u2013232. https:\/\/doi.org\/10.1016\/j.mcn.2011.04.008","DOI":"10.1016\/j.mcn.2011.04.008"},{"key":"2337_CR37","doi-asserted-by":"crossref","unstructured":"Dai L, Lin X, Wang S, Gao Y, He F (2024) The Mediterranean-dietary approaches to stop hypertension diet intervention for neurodegenerative delay (MIND) diet: a bibliometric analysis. Front Nut 11:1348808","DOI":"10.3389\/fnut.2024.1348808"},{"issue":"1","key":"2337_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW (2019) The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener 14(1):32","journal-title":"Mol Neurodegener"},{"key":"2337_CR39","unstructured":"Ebrahimi K, Majdi A, Baghaiee B, Hosseini SH, Sadigh-Eteghad S (2017) Physical activity and beta-amyloid pathology in Alzheimer\u2019s disease: a sound mind in a sound body. EXCLI J 16:959"},{"key":"2337_CR40","unstructured":"Elmi, M., (2022)\u00a0Investigating blood plasma levels of cytokines and amyloid-\u03b2 as potential diagnostic biomarkers for preclinical Alzheimer\u2019s disease. Macquarie University."},{"key":"2337_CR41","doi-asserted-by":"crossref","unstructured":"Elshazly, A.M., et al., ( 2023)\u00a0Overview of the molecular modalities and signaling pathways intersecting with \u03b2-amyloid and tau protein in Alzheimer\u2019s disease. neuroglia 4(3): p. 191\u2013208","DOI":"10.3390\/neuroglia4030014"},{"key":"2337_CR42","doi-asserted-by":"crossref","unstructured":"Fatima, A. and A. Daou, (2024)\u00a0The role of astrocytes in the relationship between amyloid-\u00df accumulation and synaptic dysfunction in Alzheimer\u2019s disease. J Stud Res 13(1)","DOI":"10.47611\/jsrhs.v13i1.6191"},{"key":"2337_CR43","doi-asserted-by":"publisher","unstructured":"Feng Y, Wang J, Zhang R, Wang Y, Wang J, Meng H, Zhang J (2024) Mediterranean diet related to 3-year incidence of cognitive decline: results from a cohort study in Chinese rural elders. Nutr Neurosci 1\u201312. https:\/\/doi.org\/10.1080\/1028415x.2024.2336715","DOI":"10.1080\/1028415x.2024.2336715"},{"key":"2337_CR44","doi-asserted-by":"crossref","unstructured":"Filipello, F., et al., (2018)\u00a0The microglial innate immune receptor TREM2 is required for synapse elimination and normal brain connectivity. Immun 48(5): p. 979\u2013991. e8.","DOI":"10.1016\/j.immuni.2018.04.016"},{"key":"2337_CR45","doi-asserted-by":"crossref","unstructured":"Fiziev, P., et al., (2023)\u00a0Rare penetrant mutations confer severe risk of common diseases. medRxiv,\u00a0","DOI":"10.1101\/2023.05.01.23289356"},{"issue":"6937","key":"2337_CR46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nature01624","volume":"423","author":"X Gabaix","year":"2003","unstructured":"Gabaix X et al (2003) A theory of power-law distributions in financial market fluctuations. Nature 423(6937):267\u2013270","journal-title":"Nature"},{"issue":"12","key":"2337_CR47","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.1002\/alz.13437","volume":"19","author":"JE Gaugler","year":"2023","unstructured":"Gaugler JE et al (2023) The intersection of social determinants of health and family care of people living with Alzheimer\u2019s disease and related dementias: a public health opportunity. Alzheimers Dement 19(12):5837\u20135846","journal-title":"Alzheimers Dement"},{"key":"2337_CR48","doi-asserted-by":"crossref","unstructured":"Gavini, V., J. Kethar, and R. Appavu, (2023)\u00a0Neuropathological mechanisms of Alzheimer\u2019s disease: complications and potential treatments. J Stud Res 12(4)","DOI":"10.47611\/jsrhs.v12i4.5645"},{"issue":"5","key":"2337_CR49","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1002\/alz.12822","volume":"19","author":"C Gillis","year":"2023","unstructured":"Gillis C et al (2023) Estimating prevalence of early Alzheimer\u2019s disease in the United States, accounting for racial and ethnic diversity. Alzheimer\u2019s & Dementia 19(5):1841\u20131848","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"2","key":"2337_CR50","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3233\/JAD-142529","volume":"47","author":"V Gilson","year":"2015","unstructured":"Gilson V et al (2015) Effects of low amyloid-\u03b2 (a\u03b2) concentration on A\u03b21-42 oligomers binding and GluN2B membrane expression. J Alzheimers Dis 47(2):453\u2013466","journal-title":"J Alzheimers Dis"},{"key":"2337_CR51","doi-asserted-by":"publisher","unstructured":"Gladyshev VN, Kritchevsky SB, Clarke SG, Cuervo AM, Fiehn O, de Magalh\u00e3es JP, Cummings SR (2021) Molecular damage in aging. Nat Aging 1(12):1096\u20131106. https:\/\/doi.org\/10.1038\/s43587-021-00150-3","DOI":"10.1038\/s43587-021-00150-3"},{"key":"2337_CR52","doi-asserted-by":"crossref","unstructured":"Goetzl EJ (2023) An emerging spectrum of therapeutic targets for Alzheimer's disease. The FASEB J 37(11):e23238","DOI":"10.1096\/fj.202301461R"},{"issue":"s1","key":"2337_CR53","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.3233\/JAD-240658","volume":"100","author":"WB Grant","year":"2024","unstructured":"Grant WB (2024) A brief history of the progress in our understanding of genetics and lifestyle, especially diet, in the risk of Alzheimer\u2019s disease. J Alzheimers Dis 100(s1):S165-s178","journal-title":"J Alzheimers Dis"},{"key":"2337_CR54","doi-asserted-by":"crossref","unstructured":"Griffiths, J. and S.G. Grant. (2023)\u00a0Synapse pathology in Alzheimer\u2019s disease. in Seminars in cell & developmental biology. Elsevier.","DOI":"10.1016\/j.semcdb.2022.05.028"},{"issue":"9","key":"2337_CR55","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.tins.2021.06.007","volume":"44","author":"A Guerrero","year":"2021","unstructured":"Guerrero A, De Strooper B, Arancibia-C\u00e1rcamo IL (2021) Cellular senescence at the crossroads of inflammation and Alzheimer\u2019s disease. Trends Neurosci 44(9):714\u2013727","journal-title":"Trends Neurosci"},{"key":"2337_CR56","doi-asserted-by":"crossref","unstructured":"Gulen MF, Samson N, Keller A, Schwabenland M, Liu C, Gl\u00fcck S, Kroese LJ (2023) cGAS\u2013 STING drives ageing-related inflammation and neurodegeneration. Nature 620(7973):374\u2013380","DOI":"10.1038\/s41586-023-06373-1"},{"issue":"10","key":"2337_CR57","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H et al (2021) The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol Psychiatry 26(10):5481\u20135503","journal-title":"Mol Psychiatry"},{"issue":"23","key":"2337_CR58","doi-asserted-by":"publisher","first-page":"15287","DOI":"10.3390\/ijms232315287","volume":"23","author":"R Hamz\u00e9","year":"2022","unstructured":"Hamz\u00e9 R et al (2022) Type 2 diabetes mellitus and Alzheimer\u2019s disease: shared molecular mechanisms and potential common therapeutic targets. Int J Mol Sci 23(23):15287","journal-title":"Int J Mol Sci"},{"issue":"15","key":"2337_CR59","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.3390\/molecules27154839","volume":"27","author":"NA Hassan","year":"2022","unstructured":"Hassan NA et al (2022) Advances on therapeutic strategies for Alzheimer\u2019s disease: from medicinal plant to nanotechnology. Molecules 27(15):4839","journal-title":"Molecules"},{"key":"2337_CR60","doi-asserted-by":"crossref","unstructured":"Hanson K, Fisher K, Hooper NM (2021) Exploiting the neuroprotective effects of \u03b1-klotho to tackle ageing-and neurodegeneration-related cognitive dysfunction. Neuron Signal 5(2):NS20200101","DOI":"10.1042\/NS20200101"},{"issue":"4","key":"2337_CR61","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT et al (2015) Neuroinflammation in Alzheimer\u2019s disease. The Lancet Neurology 14(4):388\u2013405","journal-title":"The Lancet Neurology"},{"key":"2337_CR62","doi-asserted-by":"crossref","unstructured":"Hernandez SS, Coelho FG, Gobbi S, Stella F (2010) Effects of physical activity on cognitive functions, balance and risk of falls in elderly patients with Alzheimer\u2019s dementia. Brazil J Phys Therapy 14:68\u201374","DOI":"10.1590\/S1413-35552010000100011"},{"key":"2337_CR63","doi-asserted-by":"crossref","unstructured":"Hoscheidt, S., et al., (2021)\u00a0Mediterranean and Western diet effects on Alzheimer\u2019s disease biomarkers, cerebral perfusion, and cognition in mid\u2010life: a randomized trial. Alzheimers Dement 18.","DOI":"10.1002\/alz.12421"},{"key":"2337_CR64","doi-asserted-by":"crossref","unstructured":"Hur J-Y (2022) \u03b3-Secretase in Alzheimer\u2019s disease. Exp Mol Med 54(4):433\u2013446","DOI":"10.1038\/s12276-022-00754-8"},{"issue":"1","key":"2337_CR65","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ajcnut.2023.04.025","volume":"118","author":"L Huang","year":"2023","unstructured":"Huang L, Tao Y, Chen H, Chen X, Shen J, Zhao C, Zhang R (2023) Mediterranean-dietary approaches to stop hypertension intervention for neurodegenerative delay (MIND) diet and cognitive function and its decline: a prospective study and meta-analysis of cohort studies. Am J Clin Nutr 118(1):174\u2013182","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"2337_CR66","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr et al (2024) Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimer\u2019s & Dementia 20(8):5143\u20135169","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"2337_CR67","doi-asserted-by":"crossref","unstructured":"Jackson, J.S., et al., Differential aberrant structural synaptic plasticity in axons and dendrites ahead of their degeneration in tauopathy. bioRxiv, 2020: p. 2020.04. 29.067629.","DOI":"10.1101\/2020.04.29.067629"},{"key":"2337_CR68","doi-asserted-by":"crossref","unstructured":"Janusz M, Zablocka A (2010) Colostral proline-rich polypeptides-immunoregulatory properties and prospects of therapeutic use in Alzheimer\u2019s disease. Curr Alzheimer Res 7(4):323\u2013333","DOI":"10.2174\/156720510791162377"},{"key":"2337_CR69","unstructured":"Jellinger, K.A., (2020)\u00a0Neuropathology of the Alzheimer\u2019s continuum: an update. Free Neuropathol 1."},{"issue":"1","key":"2337_CR70","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12964-024-01613-x","volume":"22","author":"M-H Jin","year":"2024","unstructured":"Jin M-H et al (2024) Exploring the role of Prx II in mitigating endoplasmic reticulum stress and mitochondrial dysfunction in neurodegeneration. Cell Communication and Signaling 22(1):231","journal-title":"Cell Communication and Signaling"},{"key":"2337_CR71","doi-asserted-by":"publisher","first-page":"101208","DOI":"10.1016\/j.arr.2020.101208","volume":"65","author":"A John","year":"2021","unstructured":"John A, Reddy PH (2021) Synaptic basis of Alzheimer\u2019s disease: focus on synaptic amyloid beta. P-Tau and Mitochondria Ageing Res Rev 65:101208","journal-title":"P-Tau and Mitochondria Ageing Res Rev"},{"issue":"1","key":"2337_CR72","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrn2970","volume":"12","author":"R Jones","year":"2011","unstructured":"Jones R (2011) Scratching an itch with VGLUT2. Nat Rev Neurosci 12(1):7\u20137","journal-title":"Nat Rev Neurosci"},{"key":"2337_CR73","first-page":"1","volume-title":"Alzheimer\u2019s disease and advanced drug delivery strategies","author":"SM Kamble","year":"2024","unstructured":"Kamble SM, Patil KR, Upaganlawar AB (2024) Etiology, pathogenesis of Alzheimer\u2019s disease and amyloid beta hypothesis. Alzheimer\u2019s disease and advanced drug delivery strategies. Elsevier, pp 1\u201311"},{"issue":"4","key":"2337_CR74","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11062-019-09823-7","volume":"51","author":"S Kaur","year":"2019","unstructured":"Kaur S, DasGupta G, Singh S (2019) Altered neurochemistry in Alzheimer\u2019s disease: targeting neurotransmitter receptor mechanisms and therapeutic strategy. Neurophysiology 51(4):293\u2013309","journal-title":"Neurophysiology"},{"issue":"4","key":"2337_CR75","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00401-020-02196-w","volume":"140","author":"SA Kent","year":"2020","unstructured":"Kent SA, Spires-Jones TL, Durrant CS (2020) The physiological roles of tau and A\u03b2: implications for Alzheimer\u2019s disease pathology and therapeutics. Acta Neuropathol 140(4):417\u2013447","journal-title":"Acta Neuropathol"},{"key":"2337_CR76","doi-asserted-by":"crossref","unstructured":"Khan T, Waseem R, Shahid M, Ansari J, Ahanger IA, Hassan I, Islam A (2023) Recent advancement in therapeutic strategies for Alzheimer\u2019s disease: insights from clinical trials. Ageing Res Rev 102113","DOI":"10.1016\/j.arr.2023.102113"},{"key":"2337_CR77","unstructured":"Khoury, Z.S., et al., (2024)\u00a0Neuroinflammation: a critical factor in neurodegenerative disorders. Cureus 16(6)"},{"key":"2337_CR78","doi-asserted-by":"crossref","unstructured":"Klemmensen, M.M., et al., (2023)\u00a0Mitochondrial dysfunction in neurodegenerative disorders. Neurother p. e00292.","DOI":"10.1016\/j.neurot.2023.10.002"},{"key":"2337_CR79","doi-asserted-by":"crossref","unstructured":"Kumar, R. and C. Azad, (2024)\u00a0Comprehensive overview of Alzheimer\u2019s disease utilizing machine learning approaches. Multimed Tools Appl","DOI":"10.1007\/s11042-024-19425-z"},{"key":"2337_CR80","doi-asserted-by":"crossref","unstructured":"Kumar, V. and K. Roy, (2023)\u00a0Recent progress in the treatment strategies for Alzheimer\u2019s disease. Computational Modeling of Drugs Against Alzheimer\u2019s Disease p. 3\u201347","DOI":"10.1007\/978-1-0716-3311-3_1"},{"issue":"3","key":"2337_CR81","doi-asserted-by":"publisher","first-page":"e1002270","DOI":"10.1371\/journal.pmed.1002270","volume":"14","author":"HM Lanoisel\u00e9e","year":"2017","unstructured":"Lanoisel\u00e9e HM et al (2017) APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: a genetic screening study of familial and sporadic cases. PLoS Med 14(3):e1002270","journal-title":"PLoS Med"},{"key":"2337_CR82","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/bs.pbr.2020.07.016","volume":"261","author":"MB Leko","year":"2021","unstructured":"Leko MB, Hof PR, \u0160imi\u0107 G (2021) Alterations and interactions of subcortical modulatory systems in Alzheimer\u2019s disease. Prog Brain Res 261:379\u2013421","journal-title":"Prog Brain Res"},{"key":"2337_CR83","doi-asserted-by":"crossref","unstructured":"Li, K.T., D. Ji, and C. Zhou, (2022)\u00a0Synaptic degeneration in neuronal circuits hinders memory recall, memory rescue, and learning. bioRxiv, p. 2022.08. 22.504766.","DOI":"10.1101\/2022.08.22.504766"},{"issue":"7113","key":"2337_CR84","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443(7113):787\u2013795","journal-title":"Nature"},{"key":"2337_CR85","doi-asserted-by":"crossref","unstructured":"Liu, N., et al., (2024)\u00a0Recent trends in treatment strategies for Alzheimer\u2019s disease and the challenges: A topical advancement. Ageing Res Rev p. 102199.","DOI":"10.1016\/j.arr.2024.102199"},{"key":"2337_CR86","doi-asserted-by":"publisher","first-page":"979869","DOI":"10.3389\/fnagi.2022.979869","volume":"14","author":"Y Liu","year":"2022","unstructured":"Liu Y et al (2022) Roles of microglial mitophagy in neurological disorders. Front Aging Neurosci 14:979869","journal-title":"Front Aging Neurosci"},{"key":"2337_CR87","doi-asserted-by":"crossref","unstructured":"Loera-Valencia R, Cedazo-Minguez A, Kenigsberg P, Page G, Duarte A, Giusti P, Cattaneo A (2019) Current and emerging avenues for Alzheimer\u2019s disease drug targets. J Int Med 286(4):398\u2013437","DOI":"10.1111\/joim.12959"},{"key":"2337_CR88","doi-asserted-by":"publisher","first-page":"888989","DOI":"10.3389\/fnagi.2022.888989","volume":"14","author":"HZ Long","year":"2022","unstructured":"Long HZ et al (2022) The role of microglia in Alzheimer\u2019s disease from the perspective of immune inflammation and iron metabolism. Front Aging Neurosci 14:888989","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"2337_CR89","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/jnc.15538","volume":"160","author":"MM Matuszyk","year":"2022","unstructured":"Matuszyk MM et al (2022) Biological and methodological complexities of beta-amyloid peptide: implications for Alzheimer\u2019s disease research. J Neurochem 160(4):434\u2013453","journal-title":"J Neurochem"},{"issue":"4","key":"2337_CR90","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/STROKEAHA.115.012506","volume":"47","author":"CRS McEntire","year":"2016","unstructured":"McEntire CRS et al (2016) Impaired arm function and finger dexterity in a nonhuman primate model of stroke. Stroke 47(4):1109\u20131116","journal-title":"Stroke"},{"key":"2337_CR91","doi-asserted-by":"publisher","first-page":"1129036","DOI":"10.3389\/fnsyn.2023.1129036","volume":"15","author":"S Meftah","year":"2023","unstructured":"Meftah S, Gan J (2023) Alzheimer\u2019s disease as a synaptopathy: evidence for dysfunction of synapses during disease progression. Frontiers in Synaptic Neuroscience 15:1129036","journal-title":"Frontiers in Synaptic Neuroscience"},{"key":"2337_CR92","doi-asserted-by":"publisher","first-page":"115522","DOI":"10.1016\/j.bcp.2023.115522","volume":"211","author":"AR Monteiro","year":"2023","unstructured":"Monteiro AR, Barbosa DJ, Remi\u00e3o F, Silva R (2023) Alzheimer\u2019s disease: insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs. Biochem Pharmacol 211:115522","journal-title":"Biochem Pharmacol"},{"key":"2337_CR93","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s40473-018-0158-5","volume":"5","author":"SS Morimoto","year":"2018","unstructured":"Morimoto SS, Manning KJ, Kim JU, Cote SE (2018) Non-pharmacological cognitive remediation strategies for treatment of depression and cognitive impairment. Curr Behav Neurosci Rep 5:198\u2013209","journal-title":"Curr Behav Neurosci Rep"},{"key":"2337_CR94","unstructured":"Morris, J., et al., (2022)\u00a0Autosomal dominant and sporadic late onset Alzheimer disease share a common in vivo pathophysiology. Brain\u00a0145."},{"issue":"9","key":"2337_CR95","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.jalz.2015.04.011","volume":"11","author":"MC Morris","year":"2015","unstructured":"Morris MC, Tangney CC, Wang Y, Sacks FM, Barnes LL, Bennett DA, Aggarwal NT (2015) MIND diet slows cognitive decline with aging. Alzheimers Dement 11(9):1015\u20131022. https:\/\/doi.org\/10.1016\/j.jalz.2015.04.011","journal-title":"Alzheimers Dement"},{"key":"2337_CR96","doi-asserted-by":"publisher","unstructured":"Mostafavi S, Gaiteri C, Sullivan SE, White CC, Tasaki S, Xu J, De Jager PL (2018) A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer\u2019s disease. Nat Neurosci 21(6):811\u2013819. https:\/\/doi.org\/10.1038\/s41593-018-0154-9","DOI":"10.1038\/s41593-018-0154-9"},{"key":"2337_CR97","doi-asserted-by":"publisher","first-page":"647054","DOI":"10.3389\/fnmol.2021.647054","volume":"14","author":"RL Mueller","year":"2021","unstructured":"Mueller RL, Combs B, Alhadidy MM, Brady ST, Morfini GA, Kanaan NM (2021) Tau: a signaling hub protein. Fron Mol Neurosci 14:647054","journal-title":"Fron Mol Neurosci"},{"key":"2337_CR98","doi-asserted-by":"publisher","unstructured":"Murman DL (2015) The impact of age on cognition. Semin Hear 36(3):111\u2013121. https:\/\/doi.org\/10.1055\/s-0035-1555115","DOI":"10.1055\/s-0035-1555115"},{"key":"2337_CR99","doi-asserted-by":"crossref","unstructured":"N\u00ed Chasaide, C. and M.A. Lynch, (2020)The role of the immune system in driving neuroinflammation. Brain neurosci adv 4: p. 2398212819901082","DOI":"10.1177\/2398212819901082"},{"issue":"6","key":"2337_CR100","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3390\/ph17060741","volume":"17","author":"SK Niazi","year":"2024","unstructured":"Niazi SK, Magoola M, Mariam Z (2024) Innovative therapeutic strategies in Alzheimer\u2019s disease: a synergistic approach to neurodegenerative disorders. Pharmaceuticals 17(6):741","journal-title":"Pharmaceuticals"},{"key":"2337_CR101","unstructured":"Noroozian, Z., (2021)\u00a0Gene immunotherapy against amyloid pathology in a mouse model of Alzheimer\u2019s disease. University of Toronto (Canada)."},{"key":"2337_CR102","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","volume":"34","author":"RJ O\u2019Brien","year":"2011","unstructured":"O\u2019Brien RJ, Wong PC (2011) Amyloid precursor protein processing and Alzheimer\u2019s disease. Annu Rev Neurosci 34:185\u2013204","journal-title":"Annu Rev Neurosci"},{"key":"2337_CR103","doi-asserted-by":"crossref","unstructured":"Onyango IG, Jauregui GV, \u010carn\u00e1 M, Bennett Jr JP, Stokin GB (2021) Neuroinflammation in Alzheimer\u2019s disease. Biomedicines 9(5):524","DOI":"10.3390\/biomedicines9050524"},{"key":"2337_CR104","doi-asserted-by":"crossref","unstructured":"Pahlavani HA (2023) Exercise therapy to prevent and treat Alzheimer\u2019s disease. Front Aging Neurosci 15:1243869","DOI":"10.3389\/fnagi.2023.1243869"},{"key":"2337_CR105","doi-asserted-by":"crossref","unstructured":"Park JC, Han SH, Mook-Jung I (2020) Peripheral inflammatory biomarkers in Alzheimer\u2019s disease: a brief review. BMB Rep 53(1):10\u201319","DOI":"10.5483\/BMBRep.2020.53.1.309"},{"issue":"36","key":"2337_CR106","doi-asserted-by":"publisher","first-page":"7218","DOI":"10.1523\/JNEUROSCI.2574-18.2019","volume":"39","author":"L Passamonti","year":"2019","unstructured":"Passamonti L et al (2019) Neuroinflammation and functional connectivity in Alzheimer\u2019s disease: interactive influences on cognitive performance. J Neurosci 39(36):7218\u20137226","journal-title":"J Neurosci"},{"issue":"9","key":"2337_CR107","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s10654-018-0380-1","volume":"33","author":"R Patterson","year":"2018","unstructured":"Patterson R et al (2018) Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysis. Eur J Epidemiol 33(9):811\u2013829","journal-title":"Eur J Epidemiol"},{"key":"2337_CR108","doi-asserted-by":"crossref","unstructured":"Pera M, Alcolea D, S\u00e1nchez-Valle R, Guardia-Laguarta C, Colom-Cadena M, Badiola N, Sepulveda-Falla D (2013) Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease. Acta Neuropathologica 125:201\u2013213","DOI":"10.1007\/s00401-012-1062-9"},{"issue":"1\u20132","key":"2337_CR109","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/jnr.23827","volume":"95","author":"CJ Pike","year":"2017","unstructured":"Pike CJ (2017) Sex and the development of Alzheimer\u2019s disease. J Neurosci Res 95(1\u20132):671\u2013680","journal-title":"J Neurosci Res"},{"key":"2337_CR110","doi-asserted-by":"crossref","unstructured":"Pires, M. and A.C. Rego, (2023)\u00a0Apoe4 and Alzheimer\u2019s disease pathogenesis-mitochondrial deregulation and targeted therapeutic strategies. Int J Mol Sci 24(1)","DOI":"10.3390\/ijms24010778"},{"issue":"1","key":"2337_CR111","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/cells13010054","volume":"13","author":"D Plantone","year":"2023","unstructured":"Plantone D et al (2023) The role of TNF-\u03b1 in Alzheimer\u2019s disease: a narrative review. Cells 13(1):54","journal-title":"Cells"},{"key":"2337_CR112","doi-asserted-by":"publisher","first-page":"21","DOI":"10.54097\/xr368202","volume":"109","author":"S Qian","year":"2024","unstructured":"Qian S (2024) Advances in Alzheimer\u2019s disease and its treatment. Highlights in Science, Engineering and Technology 109:21\u201327","journal-title":"Highlights in Science, Engineering and Technology"},{"issue":"10","key":"2337_CR113","doi-asserted-by":"publisher","first-page":"e1443","DOI":"10.1002\/mgg3.1443","volume":"8","author":"Q Qin","year":"2020","unstructured":"Qin Q et al (2020) Gene mutations associated with early onset familial Alzheimer\u2019s disease in China: an overview and current status. Mol Genet Genomic Med 8(10):e1443","journal-title":"Mol Genet Genomic Med"},{"issue":"2","key":"2337_CR114","doi-asserted-by":"publisher","first-page":"111","DOI":"10.31887\/DCNS.2009.11.2\/cqiu","volume":"11","author":"C Qiu","year":"2009","unstructured":"Qiu C, Kivipelto M, von Strauss E (2009) Epidemiology of Alzheimer\u2019s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci 11(2):111\u2013128","journal-title":"Dialogues Clin Neurosci"},{"issue":"4","key":"2337_CR115","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s43657-023-00098-x","volume":"3","author":"M Quan","year":"2023","unstructured":"Quan M et al (2023) Genetic phenotypes of Alzheimer\u2019s disease: mechanisms and potential therapy. Phenomics 3(4):333\u2013349","journal-title":"Phenomics"},{"key":"2337_CR116","doi-asserted-by":"crossref","unstructured":"Rachakatla A, Kalashikam RR (2022) Calorie restriction-regulated molecular pathways and its impact on various age groups: an overview. DNA and Cell Biology 41(5):459\u2013468","DOI":"10.1089\/dna.2021.0922"},{"key":"2337_CR117","doi-asserted-by":"crossref","unstructured":"Rajendran K, Krishnan UM (2024) Mechanistic insights and emerging therapeutic stratagems for Alzheimer\u2019s disease. Ageing Res Rev 102309","DOI":"10.1016\/j.arr.2024.102309"},{"key":"2337_CR118","doi-asserted-by":"publisher","first-page":"100149","DOI":"10.1016\/j.crphar.2022.100149","volume":"4","author":"V Rani","year":"2023","unstructured":"Rani V et al (2023) Role of pro-inflammatory cytokines in Alzheimer\u2019s disease and neuroprotective effects of pegylated self-assembled nanoscaffolds. Curr Res Pharmacol Drug Discov 4:100149","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"2337_CR119","doi-asserted-by":"publisher","first-page":"9982954","DOI":"10.1155\/2021\/9982954","volume":"2021","author":"MA Rather","year":"2021","unstructured":"Rather MA et al (2021) Inflammation and Alzheimer\u2019s disease: mechanisms and therapeutic implications by natural products. Mediators Inflamm 2021:9982954","journal-title":"Mediators Inflamm"},{"key":"2337_CR120","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/978-981-99-9404-5_13","volume-title":"Mechanism and genetic susceptibility of neurological disorders","author":"GA Rather","year":"2024","unstructured":"Rather GA et al (2024) Mitochondrial dysfunction and its role in neurological disorders. Mechanism and genetic susceptibility of neurological disorders. Springer, pp 299\u2013315"},{"issue":"1","key":"2337_CR121","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","volume":"17","author":"A-C Raulin","year":"2022","unstructured":"Raulin A-C et al (2022) ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol Neurodegener 17(1):72","journal-title":"Mol Neurodegener"},{"issue":"21","key":"2337_CR122","doi-asserted-by":"publisher","first-page":"12841","DOI":"10.3390\/ijms232112841","volume":"23","author":"P Rawat","year":"2022","unstructured":"Rawat P et al (2022) Phosphorylated tau in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci 23(21):12841","journal-title":"Int J Mol Sci"},{"key":"2337_CR123","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3389\/fimmu.2018.00586","volume":"9","author":"IM Rea","year":"2018","unstructured":"Rea IM et al (2018) Age and age-related diseases: role of inflammation triggers and cytokines. Front Immunol 9:586","journal-title":"Front Immunol"},{"issue":"5","key":"2337_CR124","doi-asserted-by":"publisher","first-page":"e512","DOI":"10.1212\/NXG.0000000000000512","volume":"6","author":"C Reitz","year":"2020","unstructured":"Reitz C, Rogaeva E, Beecham GW (2020) Late-onset vs nonmendelian early-onset Alzheimer disease. Neurology Genetics 6(5):e512","journal-title":"Neurology Genetics"},{"issue":"6","key":"2337_CR125","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1093\/brain\/awad059","volume":"146","author":"JL Robinson","year":"2023","unstructured":"Robinson JL et al (2023) Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated. Brain 146(6):2557\u20132569","journal-title":"Brain"},{"key":"2337_CR126","doi-asserted-by":"crossref","unstructured":"Romoli M, Sen A, Parnetti L, Calabresi P, Costa C (2021) Amyloid-\u03b2: a potential link between epilepsy and cognitive decline. Nat RevNeurol 17(8):469\u2013485","DOI":"10.1038\/s41582-021-00505-9"},{"key":"2337_CR127","doi-asserted-by":"crossref","unstructured":"Rostagno, A.A., (2022)\u00a0Pathogenesis of Alzheimer\u2019s disease. MDPI. p. 107","DOI":"10.3390\/ijms24010107"},{"key":"2337_CR128","doi-asserted-by":"crossref","unstructured":"Scherder E, Eggermont L, Sergeant J, Boersma F (2007) Physical activity and cognition in Alzheimer\u2019s disease: relationship to vascular risk factors, executive functions and gait. Rev Neurosci 18(2):149\u2013158","DOI":"10.1515\/REVNEURO.2007.18.2.149"},{"key":"2337_CR129","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1201\/9781003392941-3","volume-title":"Medicinal plants for the management of neurodegenerative diseases","author":"M Shahid","year":"2024","unstructured":"Shahid M, Siddiqui MR, Sajid I (2024) Ageing and oxidative stress: how they are related to developing neurodegenerative disorders. Medicinal plants for the management of neurodegenerative diseases. CRC Press, pp 20\u201348"},{"key":"2337_CR130","doi-asserted-by":"crossref","unstructured":"Shen X-N, Niu L-D, Wang Y-J, Cao X-P, Liu Q, Tan L, Zhang C, Yu J-T (2019) Inflammatory markers in Alzheimer\u2019s disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies. J Neurol Neurosurg Psychiatry 90(5):590\u2013598","DOI":"10.1136\/jnnp-2018-319148"},{"key":"2337_CR131","doi-asserted-by":"crossref","unstructured":"Shi M, Chu F, Zhu F, Zhu J (2022) Impact of anti-amyloid-\u03b2 monoclonal antibodies on the pathology and clinical profile of Alzheimer\u2019s disease: a focus on aducanumab and lecanemab. Front Aging Neurosci 14:870517","DOI":"10.3389\/fnagi.2022.870517"},{"key":"2337_CR132","unstructured":"Silva NCBS, Barha CK, Erickson KI, Kramer AF, Liu-Ambrose T (2024) Physical exercise, cognition, and brain health in aging. Trends in Neurosciences"},{"issue":"17","key":"2337_CR133","doi-asserted-by":"publisher","first-page":"9207","DOI":"10.3390\/ijms22179207","volume":"22","author":"J Sinsky","year":"2021","unstructured":"Sinsky J, Pichlerova K, Hanes J (2021) Tau protein interaction partners and their roles in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci 22(17):9207","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2337_CR134","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3233\/JAD-190577","volume":"72","author":"SG Snowden","year":"2019","unstructured":"Snowden SG et al (2019) Neurotransmitter imbalance in the brain and Alzheimer\u2019s disease pathology. Journal of Alzheimer\u2019s Disease 72(1):35\u201343","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"2337_CR135","doi-asserted-by":"crossref","unstructured":"Stanciu, G.D., et al., (2019)\u00a0Alzheimer\u2019s disease pharmacotherapy in relation to cholinergic system involvement. Biomol 10(1)","DOI":"10.3390\/biom10010040"},{"key":"2337_CR136","doi-asserted-by":"crossref","unstructured":"Sun T (2024a)\u00a0Risk factors contributing to the development of Alzheimer\u2019s disease. E3S Web of Conferences, p 553","DOI":"10.1051\/e3sconf\/202455305017"},{"key":"2337_CR137","doi-asserted-by":"crossref","unstructured":"Sun T (2024b) Risk factors contributing to the development of Alzheimer\u2019s disease. Paper presented at the E3S Web of Conferences","DOI":"10.1051\/e3sconf\/202455305017"},{"issue":"1","key":"2337_CR138","doi-asserted-by":"publisher","first-page":"e12007","DOI":"10.1002\/trc2.12007","volume":"6","author":"K Suzuki","year":"2020","unstructured":"Suzuki K et al (2020) Effect of apolipoprotein E \u03b54 allele on the progression of cognitive decline in the early stage of Alzheimer\u2019s disease. Alzheimers Dement (n y) 6(1):e12007","journal-title":"Alzheimers Dement (n y)"},{"key":"2337_CR139","doi-asserted-by":"crossref","unstructured":"Tcw, J. and A.M. Goate, (2017)\u00a0Genetics of \u03b2-amyloid precursor protein in Alzheimer\u2019s disease. Cold Spring Harb Perspect Med 7(6).","DOI":"10.1101\/cshperspect.a024539"},{"key":"2337_CR140","doi-asserted-by":"crossref","unstructured":"Tenchov, R., J. Sasso, and Q.A. Zhou, (2024)\u00a0Alzheimer\u2019s disease: exploring the landscape of cognitive decline","DOI":"10.26434\/chemrxiv-2024-f0zz5"},{"key":"2337_CR141","doi-asserted-by":"crossref","unstructured":"Tsai, H.-H., et al., (2024)\u00a0Cerebral tau pathology in cerebral amyloid angiopathy. Brain Commun 6(2): p. fcae086","DOI":"10.1093\/braincomms\/fcae086"},{"key":"2337_CR142","doi-asserted-by":"crossref","unstructured":"Uddin, J., et al., (2024)\u00a0Factors contributing to Alzheimer\u2019s disease in older adult populations: a narrative review, in Preprints. Preprints.","DOI":"10.20944\/preprints202406.1892.v1"},{"issue":"1","key":"2337_CR143","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/s41467-020-15701-2","volume":"11","author":"JW Vogel","year":"2020","unstructured":"Vogel JW et al (2020) Spread of pathological tau proteins through communicating neurons in human Alzheimer\u2019s disease. Nat Commun 11(1):2612","journal-title":"Nat Commun"},{"key":"2337_CR144","unstructured":"Walker, L.C., (2020)\u00a0A\u03b2 plaques. Free neuropathol 1"},{"issue":"1","key":"2337_CR145","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41531-021-00213-7","volume":"7","author":"H Wang","year":"2021","unstructured":"Wang H et al (2021) Genetic and environmental factors in Alzheimer\u2019s and Parkinson\u2019s diseases and promising therapeutic intervention via fecal microbiota transplantation. NPJ Parkinsons Dis 7(1):70","journal-title":"NPJ Parkinsons Dis"},{"issue":"4","key":"2337_CR146","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson","year":"2023","unstructured":"Wilson DM et al (2023) Hallmarks of neurodegenerative diseases. Cell 186(4):693\u2013714","journal-title":"Cell"},{"issue":"1","key":"2337_CR147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2016.07.150","volume":"13","author":"A Wimo","year":"2017","unstructured":"Wimo A et al (2017) The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimers Dement 13(1):1\u20137","journal-title":"Alzheimers Dement"},{"issue":"9","key":"2337_CR148","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/s1474-4422(08)70170-","volume":"7","author":"T Wisniewski","year":"2008","unstructured":"Wisniewski T, Konietzko U (2008) Amyloid-beta immunisation for Alzheimer\u2019s disease. Lancet Neurol 7(9):805\u2013811. https:\/\/doi.org\/10.1016\/s1474-4422(08)70170-","journal-title":"Lancet Neurol"},{"issue":"6","key":"2337_CR149","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.14336\/AD.2022.0412","volume":"13","author":"T Wu","year":"2022","unstructured":"Wu T et al (2022) Amyloid cascade hypothesis for the treatment of Alzheimer\u2019s disease: progress and challenges. Aging Dis 13(6):1745\u20131758","journal-title":"Aging Dis"},{"issue":"4","key":"2337_CR150","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.3390\/ijms24043841","volume":"24","author":"Z Yang","year":"2023","unstructured":"Yang Z, Zou Y, Wang L (2023) Neurotransmitters in prevention and treatment of Alzheimer\u2019s disease. Int J Mol Sci 24(4):3841","journal-title":"Int J Mol Sci"},{"key":"2337_CR151","doi-asserted-by":"publisher","first-page":"e933084","DOI":"10.12659\/MSM.933084","volume":"27","author":"X Yin","year":"2021","unstructured":"Yin X et al (2021) The role of amyloid-beta and tau in the early pathogenesis of Alzheimer\u2019s disease. Med Sci Monit 27:e933084","journal-title":"Med Sci Monit"},{"issue":"178","key":"2337_CR152","doi-asserted-by":"publisher","first-page":"757","DOI":"10.24976\/Discov.Med.202335178.71","volume":"35","author":"C Zhang","year":"2023","unstructured":"Zhang C (2023) Etiology of Alzheimer\u2019s disease. Discov Med 35(178):757\u2013776","journal-title":"Discov Med"},{"key":"2337_CR153","doi-asserted-by":"crossref","unstructured":"Zempel H, Mandelkow E (2019) Mechanisms of axonal sorting of tau and influence of the axon initial segment on tau cell polarity. Tau Biology 69\u201377","DOI":"10.1007\/978-981-32-9358-8_6"},{"issue":"1","key":"2337_CR154","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W et al (2023a) Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther 8(1):267","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2337_CR155","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y et al (2023b) Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Signal Transduct Target Ther 8(1):248","journal-title":"Signal Transduct Target Ther"},{"key":"2337_CR156","first-page":"719","volume":"74","author":"Y Zhong","year":"2023","unstructured":"Zhong Y (2023) Cutting edge research on drug treatment strategies and emerging therapies for Alzheimer\u2019s Disease. High Sci Eng Technol 74:719\u2013726","journal-title":"High Sci Eng Technol"},{"issue":"1","key":"2337_CR157","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12979-024-00445-0","volume":"21","author":"Q Zhang","year":"2024","unstructured":"Zhang Q et al (2024) Neuroinflammation in Alzheimer\u2019s disease: insights from peripheral immune cells. Immunity & Ageing 21(1):38","journal-title":"Immunity & Ageing"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-025-02337-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-025-02337-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-025-02337-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:03:21Z","timestamp":1751357001000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-025-02337-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":157,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["2337"],"URL":"https:\/\/doi.org\/10.1007\/s12031-025-02337-4","relation":{},"ISSN":["1559-1166"],"issn-type":[{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"8 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"57"}}